Arbutus Biopharma Corp — Director's Dealing 2021

Feb 10, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arbutus Biopharma Corp (ABUS)
CIK: 0001447028
Period of Report: 2021-02-09

Reporting Person: McElhaugh Michael J. (Chief Business Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-09	Common Stock	S	20000	$5	Disposed	1307457	Direct

Footnotes

F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2020.